Uzay, A. 2020. Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease. Biology Of Blood And Marrow Transplantation , vol.26, no.3 , 191-192.

Uzay, A., (2020). Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease. Biology Of Blood And Marrow Transplantation , vol.26, no.3, 191-192.

Uzay, Ant. "Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease," Biology Of Blood And Marrow Transplantation , vol.26, no.3, 191-192, 2020

Uzay, Ant. "Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease." Biology Of Blood And Marrow Transplantation , vol.26, no.3, pp.191-192, 2020

Uzay, A. (2020) . "Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease." Biology Of Blood And Marrow Transplantation , vol.26, no.3, pp.191-192.

@article{article, author={Ant UZAY}, title={Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease}, journal={Biology Of Blood And Marrow Transplantation}, year=2020, pages={191-192} }